75N91018F00077: Leidos Biomedical Research Inc · FederalPipeline
75N91018F00077: Leidos Biomedical Research Inc
Delivery Order to Leidos Biomedical Research Inc by National Institutes of Health: $53.5M obligated, latest action 2025-08-22. Cell-based Immunotherapy…